PriceTargets.com logo

Organigram - OGI Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: C$3.85
  • Forecasted Upside: 50.39%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$2.56 As of 04/25/2024 01:00 AM ET
▼ -0.1 (-3.76%)

This chart shows the closing price for OGI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Organigram Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OGI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OGI

Analyst Price Target is C$3.85
▲ +50.39% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Organigram in the last 3 months. The average price target is C$3.85, with a high forecast of C$5.25 and a low forecast of C$2.70. The average price target represents a 50.39% upside from the last price of C$2.56.

This chart shows the closing price for OGI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in Organigram. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/3/2024ATB CapitalSet TargetOutperformC$5.25
2/27/2024Jefferies Financial GroupLower TargetBuyC$4.95 ➝ C$4.40
2/14/2024Alliance Global PartnersBoost TargetNeutralC$2.00 ➝ C$2.70
12/20/2023ATB CapitalBoost TargetOutperformC$5.50 ➝ C$6.50
12/20/2023Alliance Global PartnersLower TargetC$2.25 ➝ C$2.00
12/20/2023Canaccord Genuity GroupLower TargetC$4.00 ➝ C$3.75
7/18/2023Haywood SecuritiesLower TargetC$5.00 ➝ C$3.00
7/17/2023Stifel NicolausBoost TargetC$1.25 ➝ C$4.00
7/17/2023Alliance Global PartnersBoost TargetC$1.00 ➝ C$2.25
7/17/2023ATB CapitalLower TargetC$9.00 ➝ C$6.50
7/17/2023Canaccord Genuity GroupLower TargetC$9.00 ➝ C$4.00
4/21/2023Jefferies Financial GroupLower TargetC$1.80 ➝ C$1.50
4/13/2023ATB CapitalLower TargetC$2.50 ➝ C$2.25
4/13/2023Canaccord Genuity GroupLower TargetC$3.25 ➝ C$2.25
4/13/2023Haywood SecuritiesLower TargetC$1.60 ➝ C$1.25
4/13/2023Stifel NicolausLower TargetC$1.50 ➝ C$1.25
2/28/2023Jefferies Financial GroupLower TargetC$2.00 ➝ C$1.80
1/13/2023Alliance Global PartnersLower TargetC$1.50 ➝ C$1.30
1/13/2023Stifel NicolausUpgradeHold ➝ Buy
12/23/2022Jefferies Financial GroupLower TargetC$2.60 ➝ C$2.00
8/31/2022Eight CapitalLower TargetC$2.60 ➝ C$1.70
7/19/2022Jefferies Financial GroupLower TargetMarket PerformC$3.34 ➝ C$2.60
7/15/2022Haywood SecuritiesLower TargetHoldC$2.50 ➝ C$1.90
7/15/2022Stifel NicolausLower TargetC$2.25 ➝ C$1.50
4/14/2022Raymond JamesSet TargetOverweightC$3.00
4/13/2022Jefferies Financial GroupLower TargetC$3.44 ➝ C$3.34
4/13/2022ATB CapitalUpgradeSector Perform ➝ OutperformC$3.00
4/12/2022Atb Cap MarketsUpgradeSector Perform ➝ Outperform
3/15/2022Raymond JamesLower TargetOutperformC$5.00 ➝ C$3.00
1/12/2022ATB CapitalBoost TargetSector PerformC$2.65 ➝ C$3.00
1/12/2022Canaccord Genuity GroupUpgradeHold ➝ Speculative BuyC$3.00 ➝ C$3.25
1/10/2022Raymond JamesReiterated RatingOutperformC$5.00
1/7/2022Alliance Global PartnersLower TargetNeutral ➝ UnderperformC$4.00 ➝ C$2.25
12/22/2021Raymond JamesReiterated RatingOutperformC$5.00
11/30/2021Jefferies Financial GroupLower TargetMarket PerformC$3.83 ➝ C$3.49
11/25/2021Raymond JamesSet TargetOutperformC$5.00
11/24/2021Alliance Global PartnersLower TargetUnderperformC$3.75 ➝ C$3.00
11/24/2021ATB CapitalLower TargetC$4.25 ➝ C$2.65
11/19/2021Raymond JamesSet TargetOutperformC$5.00
9/24/2021CIBCReiterated RatingNeutral
9/23/2021CIBCLower TargetNAC$4.00 ➝ C$3.50
9/15/2021Raymond JamesReiterated RatingOutperformC$5.00
9/3/2021Jefferies Financial GroupBoost TargetC$3.57 ➝ C$3.83
8/5/2021Raymond JamesReiterated RatingOutperformC$5.00
7/23/2021Atb Cap MarketsReiterated RatingSector Perform
7/14/2021Raymond JamesReiterated RatingOutperformC$5.00
7/14/2021ATB CapitalBoost TargetNAC$3.75 ➝ C$4.25
7/14/2021CIBCBoost TargetC$3.75 ➝ C$4.00
7/9/2021CIBCReiterated RatingNeutralC$3.75
7/8/2021Raymond JamesReiterated RatingOutperformC$5.00
6/11/2021CIBCBoost TargetUnderperformC$3.25 ➝ C$3.75
5/11/2021CIBCUpgradeUnderperform ➝ Neutral
5/11/2021Royal Bank of CanadaUpgradeNeutral
5/4/2021Raymond JamesReiterated RatingOutperformC$5.00
4/22/2021Jefferies Financial GroupBoost TargetC$3.48 ➝ C$3.57
4/15/2021Alliance Global PartnersLower TargetUnderpeformC$4.00 ➝ C$3.75
4/14/2021Haywood SecuritiesLower TargetUnderperformC$4.75 ➝ C$3.50
4/14/2021ATB CapitalLower TargetUnderperformC$4.20 ➝ C$3.75
4/14/2021Alliance Global PartnersBoost TargetUnderperformC$3.75 ➝ C$4.00
4/14/2021CIBCDowngradeNeutral ➝ UnderperformC$5.00 ➝ C$3.25
4/13/2021Raymond JamesLower TargetOutperformC$6.00 ➝ C$5.00
4/7/2021Raymond JamesReiterated RatingOutperformC$6.00
4/6/2021CIBCReiterated RatingNeutralC$5.00
3/12/2021Raymond JamesBoost TargetOUTPERFORMC$3.00 ➝ C$6.00
3/12/2021ATB CapitalBoost TargetNAC$1.90 ➝ C$4.20
3/12/2021CIBCBoost TargetNAC$4.25 ➝ C$5.00
3/12/2021Eight CapitalBoost TargetNAC$2.40 ➝ C$3.85
1/22/2021Jefferies Financial GroupLower TargetMarket PerformC$3.48
1/13/2021Alliance Global PartnersDowngradeBuy ➝ Neutral
1/13/2021Eight CapitalLower TargetC$3.50 ➝ C$2.00
1/11/2021Raymond JamesUpgradeMarket Perform ➝ OutperformC$3.00
12/8/2020Raymond JamesReiterated RatingMarket PerformC$3.00
12/4/2020Jefferies Financial GroupBoost TargetC$3.79 ➝ C$3.89
12/1/2020CIBCBoost TargetC$2.00 ➝ C$2.25
12/1/2020Haywood SecuritiesLower TargetHoldC$2.50 ➝ C$2.00
11/23/2020Raymond JamesLower TargetMarket PerformC$5.00 ➝ C$3.00
10/1/2020Raymond JamesSet TargetMarket PerformC$5.00
9/16/2020Cantor FitzgeraldBoost TargetC$5.00 ➝ C$5.35
8/5/2020Jefferies Financial GroupLower TargetC$4.50 ➝ C$3.79
7/23/2020Eight CapitalLower TargetC$4.00 ➝ C$3.50
7/22/2020Raymond JamesSet TargetMarket PerformC$5.00
7/22/2020ATB CapitalDowngradeOutperform ➝ Sector PerformC$4.10 ➝ C$2.30
7/22/2020CIBCLower TargetC$2.75 ➝ C$2.00
7/22/2020CormarkLower TargetC$3.50 ➝ C$2.25
7/21/2020Pi FinancialReiterated RatingBuy
7/21/2020AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
7/7/2020Alliance Global PartnersReiterated RatingBuyC$4.00
7/6/2020Jefferies Financial GroupLower TargetC$5.00 ➝ C$4.50
6/29/2020Raymond JamesDowngradeOutperform ➝ Market PerformC$6.50 ➝ C$5.00
6/1/2020Raymond JamesSet TargetOutperformC$6.50
5/17/2020Raymond JamesSet TargetOutperformC$6.50
4/23/2020Raymond JamesSet TargetOutperformC$6.50
4/16/2020Jefferies Financial GroupLower TargetC$5.50 ➝ C$5.00
4/15/2020CIBCDowngradeOutperform ➝ NeutralC$5.00 ➝ C$2.75
4/15/2020Haywood SecuritiesLower TargetC$5.50 ➝ C$4.75
4/15/2020Pi FinancialLower TargetBuyC$7.00 ➝ C$5.50
4/15/2020AltaCorp CapitalUpgradeSector Perform ➝ OutperformC$5.50 ➝ C$4.10
4/15/2020Eight CapitalLower TargetC$7.00 ➝ C$4.00
4/15/2020Stifel NicolausLower TargetC$10.00 ➝ C$6.00
4/14/2020Raymond JamesLower TargetOutperformC$9.00 ➝ C$6.50
4/8/2020Raymond JamesSet TargetOutperformC$9.00
3/24/2020Raymond JamesSet TargetOutperformC$9.00
1/20/2020Jefferies Financial GroupBoost TargetC$5.00 ➝ C$5.50
1/16/2020Pi FinancialSet TargetBuyC$7.00
1/15/2020Raymond JamesSet TargetOutperformC$9.00
1/10/2020CIBCLower TargetC$9.00 ➝ C$5.00
1/9/2020Raymond JamesDowngradeOutperform ➝ Market PerformC$9.00
1/2/2020Jefferies Financial GroupLower TargetC$8.20 ➝ C$5.00
11/26/2019AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
11/26/2019CormarkLower TargetC$10.00 ➝ C$4.50
11/26/2019Haywood SecuritiesLower TargetC$8.00 ➝ C$7.50
11/26/2019Pi FinancialSet TargetBuyC$7.00
11/26/2019Raymond JamesSet TargetOutperformC$9.00
11/25/2019Beacon SecuritiesDowngradeBuy ➝ Hold
11/13/2019Raymond JamesSet TargetOutperformC$9.00
11/12/2019AltaCorp CapitalLower TargetC$13.15 ➝ C$6.50
11/5/2019Cantor FitzgeraldReiterated RatingOverweight
10/11/2019Jefferies Financial GroupUpgradeHold ➝ BuyC$10.50 ➝ C$8.20
9/24/2019CIBCSet TargetOutperformC$9.00
6/2/2019AltaCorp CapitalReiterated RatingOutperform
5/3/2019Jefferies Financial GroupDowngradeBuy ➝ HoldC$10.00 ➝ C$10.50
(Data available from 4/26/2019 forward)

News Sentiment Rating

0.46 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 5 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/26/2024
  • 1 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 1 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Organigram logo
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: C$2.56
Low: C$2.53
High: C$2.62

50 Day Range

MA: C$2.84
Low: C$2.53
High: C$3.67

52 Week Range

Now: C$2.56
Low: C$1.35
High: C$3.95

Volume

229,498 shs

Average Volume

397,651 shs

Market Capitalization

C$240.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Organigram?

The following Wall Street analysts have issued reports on Organigram in the last year: Alliance Global Partners, ATB Capital, Canaccord Genuity Group Inc., Haywood Securities, Jefferies Financial Group Inc., and Stifel Nicolaus.
View the latest analyst ratings for OGI.

What is the current price target for Organigram?

6 Wall Street analysts have set twelve-month price targets for Organigram in the last year. Their average twelve-month price target is C$3.85, suggesting a possible upside of 50.4%. ATB Capital has the highest price target set, predicting OGI will reach C$5.25 in the next twelve months. Alliance Global Partners has the lowest price target set, forecasting a price of C$2.70 for Organigram in the next year.
View the latest price targets for OGI.

What is the current consensus analyst rating for Organigram?

Organigram currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for OGI.

What other companies compete with Organigram?

Other companies that are similar to Organigram include ICC Labs, Leaf Mobile, Supreme Cannabis, ESSA Pharma and RIV Capital. Learn More about companies similar to Organigram.

How do I contact Organigram's investor relations team?

Organigram's physical mailing address is 333 Bay Street, Suite 1250, Toronto, ON M5H 2R2, Canada, . The company's listed phone number is 844-644-4726. The official website for Organigram is www.organigram.ca. Learn More about contacing Organigram investor relations.